Answer to Question 1
Correct Answer: 4
Rationale 1: There were higher profits for studying on-patent, not off-patent, drugs.
Rationale 2: Congress did not choose the drugs to be researched; that decision was left to the pharmaceutical companies.
Rationale 3: Most of the drugs that were studied were chosen because of financial benefits, not for their potential value to pediatric drug research.
Rationale 4: Most of the drugs studied were in adult drug classes. The main rationale for the pharmaceutical companies' choice of drugs for the studies was financial.
Global Rationale: Most of the drugs studied were in adult drug classes. The main rationale for the pharmaceutical companies' choice of drugs for the studies was financial. There were higher profits for studying on-patent, not off-patent, drugs. Congress did not choose the drugs to be researched; that decision was left to the pharmaceutical companies. Most of the drugs that were studied were chosen because of financial benefits, not for their potential value to pediatric drug research.
Answer to Question 2
Correct Answer: 2
Rationale 1: This was not the purpose of the legislation.
Rationale 2: The Food and Drug Administration Modernization Act was passed to improve testing and labeling of pediatric drugs.
Rationale 3: This was not the purpose of the legislation.
Rationale 4: There was a financial incentive for the research, but not for this purpose.
Global Rationale: The Food and Drug Administration Modernization Act was passed to improve testing and labeling of pediatric drugs. There was a financial incentive for the research, but not for this purpose.